Pharmacotherapy

The relationship between obesity and disordered eating behaviors represents a complex combination of psychological, physiological and environmental influences.

Patients with cancer who received specialized mental health support experienced improved quality of life, as well as reduced pain, depression and fatigue.

Over the last 50 years, revascularization and pharmacotherapeutic innovations have led to significant reductions in major adverse CV events associated with both acute and chronic coronary diseases.

Women with polycystic ovary syndrome, obesity and irregular menses were more than twice as likely to experience spontaneous ovulation during the year after undergoing bariatric surgery compared with medical therapy, researchers reported.

SAN DIEGO — A third of patients with obstructive sleep apnea had an apnea-hypopnea index less than 10 events per hour after oral appliance therapy, according to research presented at the American Thoracic Society International Conference.

Last month, the Obesity Medicine Association held its annual conference, where clinicians across the country came together to discuss the latest developments in obesity care.

In patients with the obesity phenotype of HF with preserved ejection, semaglutide 2.4 mg improved HF-related symptoms and physical limitations vs. placebo regardless of diuretic use, according to new data from the STEP-HFpEF trials.

Cytisinicline was associated with a greater rate of nicotine-containing e-cigarette cessation compared with placebo during 12 weeks of treatment and up to 4 weeks posttreatment, according to results from the phase 2 ORCA-VI trial.

DENVER — Individualized care is critical for treating childhood obesity, according to a presenter at the Obesity Medicine Association’s annual conference.

Pharmacists are one of the most accessible health care providers and singularly well positioned to lead efforts in integrating pharmacogenomics testing to improve medication-related outcomes.